Clinical Outcomes; Clinical Research; Health Services Research; Immunotherapy; Nutrition; Obesity; Pediatric Hematology-Oncology; Pediatrics
Dr. Kara Kelly is the Waldemar J. Kaminski Endowed Chair of Pediatrics and Professor of Oncology at Roswell Park Comprehensive Cancer Center and Division Chief of Pediatric Hematology/Oncology at Oishei Children’s Hospital and the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo where she also is a Professor of Pediatrics. A pediatric oncologist with expertise in the care of children and adolescents with leukemia and lymphoma, Dr. Kelly has been chair of the Hodgkin lymphoma committee for the Children’s Oncology Group since 2011. In her current role, she oversees the development and conduct of a large portfolio of clinical trials and correlative studies aimed at improving the care of children and adolescents with Hodgkin lymphoma through the integration of novel therapeutic strategies. Dr. Kelly is a member of the Scientific Advisory Board of the Lymphoma Research Foundation where she has focused on improving outcomes in adolescents and young adults with lymphoma. Dr. Kelly’s research interests also extend to pediatric acute lymphoblastic leukemia where she has been a long standing member of the Dana Farber Cancer Institute ALL Consortium, and leads studies investigating nutrition related factors contributing to treatment toxicity as well as development of interventions to improve adherence to oral chemotherapy.
Clinical Outcomes, Clinical Research, Health Services Research, Immunotherapy, Nutrition, Obesity, Pediatric Hematology-Oncology, Pediatrics
This UBMD physician is also a member of the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, teaching the next generation of doctors and researching to advance care in WNY and beyond. Learn more about this physician's research and teaching activities, as well as view credentials, publications, professional involvement and more below.